{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:50:14Z","timestamp":1791039014273,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1124\/mol.107.038158","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T05:06:11Z","timestamp":1183007171000},"page":"653-664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Exacerbation of Dopaminergic Terminal Damage in a Mouse Model of Parkinson\u2019s Disease by the G-Protein-Coupled Receptor Protease-Activated Receptor 1"],"prefix":"10.1016","volume":"72","author":[{"given":"Cecily E.","family":"Hamill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Michael","family":"Caudle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt D.","family":"Pennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Traynelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.107.038158_REF1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0361-9230(89)90157-3","article-title":"The acute histopathology of MPTP in the mouse CNS","volume":"23","author":"Adams","year":"1989","journal-title":"Brain Res Bull"},{"key":"10.1124\/mol.107.038158_REF2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/abio.1999.4356","article-title":"An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors","volume":"277","author":"Altrogge","year":"2000","journal-title":"Anal Biochem"},{"key":"10.1124\/mol.107.038158_REF3","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1471-4159.1998.71041635.x","article-title":"Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice","volume":"71","author":"Aubin","year":"1998","journal-title":"J Neurochem"},{"key":"10.1124\/mol.107.038158_REF4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2003.tb07470.x","article-title":"Mitochondria, oxidative damage, and inflammation in Parkinson\u2019s disease","volume":"991","author":"Beal","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/mol.107.038158_REF5","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1021\/jm960455s","article-title":"Development of potent thrombin receptor antagonist peptides","volume":"39","author":"Bernatowicz","year":"1996","journal-title":"J Med Chem"},{"key":"10.1124\/mol.107.038158_REF6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/08977199409015048","article-title":"The anion-binding exosite is critical for the high affinity binding of thrombin to the human thrombin receptor","volume":"11","author":"Blackhart","year":"1994","journal-title":"Growth Factors"},{"key":"10.1124\/mol.107.038158_REF7","doi-asserted-by":"crossref","first-page":"C681","DOI":"10.1152\/ajpcell.2001.281.2.C681","article-title":"Factor Xa is a fibroblast mitogen via binding to effector-cell protease receptor-1 and autocrine release of PDGF","volume":"281","author":"Blanc-Brude","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/mol.107.038158_REF8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2004.12.018","article-title":"PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells","volume":"120","author":"Boire","year":"2005","journal-title":"Cell"},{"key":"10.1124\/mol.107.038158_REF9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neulet.2004.10.089","article-title":"Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson\u2019s disease model","volume":"373","author":"Cannon","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1124\/mol.107.038158_REF10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2006.07.094","article-title":"Protease-activated receptor-1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"1116","author":"Cannon","year":"2006","journal-title":"Brain Research"},{"key":"10.1124\/mol.107.038158_REF11","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1046\/j.1471-4159.2003.01634.x","article-title":"Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia","volume":"84","author":"Carre\u00f1o-Muller","year":"2003","journal-title":"J Neurochem"},{"key":"10.1124\/mol.107.038158_REF12","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease","volume":"60","author":"Chen","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1124\/mol.107.038158_REF13","doi-asserted-by":"crossref","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson\u2019s disease","volume":"21","author":"Chen","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/mol.107.038158_REF14","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1523\/JNEUROSCI.23-13-05877.2003","article-title":"Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo","volume":"23","author":"Choi","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/mol.107.038158_REF15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0969-9961(03)00085-8","article-title":"Thrombin induces nigral dopaminergic neurodegeneration in vivo by altering expresion of death-related proteins","volume":"14","author":"Choi","year":"2003","journal-title":"Neurobiology of Disease"},{"key":"10.1124\/mol.107.038158_REF16","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/j.1471-4159.2005.03503.x","article-title":"Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo","volume":"95","author":"Choi","year":"2005","journal-title":"J Neurochem"},{"key":"10.1124\/mol.107.038158_REF17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-0270(94)90022-1","article-title":"[3H]WIN 35,428 binding to the dopamine uptake carrier. I. Effect of tonicity and buffer composition","volume":"51","author":"Coffey","year":"1994","journal-title":"J Neurosci Methods"},{"key":"10.1124\/mol.107.038158_REF18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/381516a0","article-title":"Role of the thrombin receptor in development and evidence for a second receptor","volume":"381","author":"Connolly","year":"1996","journal-title":"Nature"},{"key":"10.1124\/mol.107.038158_REF19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/neur.1996.0020","article-title":"Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson\u2019s disease mice model","volume":"5","author":"Czlonkowska","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1124\/mol.107.038158_REF20","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1111\/j.0953-816X.2004.03372.x","article-title":"Deleterious effects of minocycline in animal models of Parkinson\u2019s disease and Huntington\u2019s disease","volume":"19","author":"Diguet","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.107.038158_REF21","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.1073\/pnas.251341998","article-title":"Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease","volume":"98","author":"Du","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.107.038158_REF22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.taap.2005.06.003","article-title":"Pyrethroid pesticide-induced alterations in dopamine transporter function","volume":"211","author":"Elwan","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/mol.107.038158_REF23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1471-4159.2004.02399.x","article-title":"Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum","volume":"89","author":"Ferger","year":"2004","journal-title":"J Neurochem"},{"key":"10.1124\/mol.107.038158_REF24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0892-0362(94)00048-I","article-title":"Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatum","volume":"17","author":"Francis","year":"1995","journal-title":"Neurotoxicol Teratol"},{"key":"10.1124\/mol.107.038158_REF25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nbd.2005.10.008","article-title":"Thrombin-induced delayed injury involves multiple and distinct signaling pathways in the cerebral cortex and the striatum in organotypic slice cultures","volume":"22","author":"Fujimoto","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1124\/mol.107.038158_REF26","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1096\/fj.03-0203fje","article-title":"Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson\u2019s disease","volume":"17","author":"Gao","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/mol.107.038158_REF27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/jnr.10835","article-title":"Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system","volume":"74","author":"Gardner","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1124\/mol.107.038158_REF28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-3806(01)00315-7","article-title":"Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide","volume":"133","author":"Gayle","year":"2002","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1124\/mol.107.038158_REF29","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1128\/JVI.75.14.6572-6583.2001","article-title":"Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia","volume":"75","author":"Ghorpade","year":"2001","journal-title":"J Virol"},{"key":"10.1124\/mol.107.038158_REF30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0166-2236(00)01617-9","article-title":"Serine proteases and brain damage - is there a link?","volume":"23","author":"Gingrich","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1124\/mol.107.038158_REF31","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0022-3565(25)24767-X","article-title":"Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice","volume":"257","author":"Giovanni","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.038158_REF32","first-page":"29","article-title":"Special lecture: glial reactivity after damage: implications for scar formation and neuronal recovery","volume":"52","author":"Hamill","year":"2005","journal-title":"Clin Neurosurg"},{"key":"10.1124\/mol.107.038158_REF33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.molbrainres.2005.01.009","article-title":"A role of IL-1 in MPTP-induced changes in striatal dopaminergic and serotoninergic transporter binding: clues from interleukin-1 type I receptor-deficient mice","volume":"136","author":"H\u00e9bert","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1124\/mol.107.038158_REF34","series-title":"Comparative Cytoarchitectonic Atlas of C57Bl\/6 and 129\/SV Mouse Brain","author":"Hof","year":"2000"},{"key":"10.1124\/mol.107.038158_REF35","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1139\/y97-110","article-title":"Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides","volume":"75","author":"Hollenberg","year":"1997","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/mol.107.038158_REF36","doi-asserted-by":"crossref","first-page":"C1347","DOI":"10.1152\/ajpcell.00304.2002","article-title":"PARs in the stars: proteinase-activated receptors and astrocyte function. Focus on \u201cThrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways\u201d","volume":"283","author":"Hollenberg","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/mol.107.038158_REF37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/01.jnen.0000195941.48033.eb","article-title":"Up-regulation of protease-activated receptor-1 in astrocytes in Parkinson\u2019s disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase","volume":"65","author":"Ishida","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1124\/mol.107.038158_REF38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1538-7836.2004.00545.x","article-title":"Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells","volume":"2","author":"Jiang","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1124\/mol.107.038158_REF39","first-page":"236","article-title":"Thrombin and factor Xa enhance the production of interleukin-1","volume":"71","author":"Jones","year":"1990","journal-title":"Immunology"},{"key":"10.1124\/mol.107.038158_REF40","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.expneurol.2004.02.018","article-title":"Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes","volume":"188","author":"Junge","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1124\/mol.107.038158_REF41","doi-asserted-by":"crossref","first-page":"13019","DOI":"10.1073\/pnas.2235594100","article-title":"The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia","volume":"100","author":"Junge","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.107.038158_REF42","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000","article-title":"Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia","volume":"20","author":"Kim","year":"2000","journal-title":"J Neurosci"},{"key":"10.1124\/mol.107.038158_REF43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","article-title":"Microglial and astrocytic involvement in a murine model of Parkinson\u2019s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"39","author":"Kohutnicka","year":"1998","journal-title":"Immunopharmacology"},{"key":"10.1124\/mol.107.038158_REF44","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1021\/bi9824792","article-title":"Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy","volume":"38","author":"Kuliopulos","year":"1999","journal-title":"Biochemistry"},{"key":"10.1124\/mol.107.038158_REF45","doi-asserted-by":"crossref","first-page":"23151","DOI":"10.1074\/jbc.M314192200","article-title":"LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1\/2 pathway [published erratum appears in J Biol Chem 282:2752, 2007]","volume":"279","author":"Kunapuli","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.038158_REF46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/exnr.1998.6993","article-title":"The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse","volume":"156","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1124\/mol.107.038158_REF47","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1124\/mol.107.038158_REF48","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1124\/mol.107.038158_REF49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","article-title":"Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain","volume":"39","author":"Lawson","year":"1990","journal-title":"Neuroscience"},{"key":"10.1124\/mol.107.038158_REF50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/glia.20190","article-title":"Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways","volume":"51","author":"Lee da","year":"2005","journal-title":"Glia"},{"key":"10.1124\/mol.107.038158_REF51","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat Med"},{"key":"10.1124\/mol.107.038158_REF52","doi-asserted-by":"crossref","first-page":"16977","DOI":"10.1016\/S0021-9258(19)47326-2","article-title":"The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity","volume":"266","author":"Liu","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.038158_REF53","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2013\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1124\/mol.107.038158_REF54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/exnr.2002.8019","article-title":"Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson\u2019s disease","volume":"178","author":"Lorenzl","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1124\/mol.107.038158_REF55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2003.10.015","article-title":"Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy","volume":"218","author":"Lorenzl","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1124\/mol.107.038158_REF56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0031-6997(24)01493-5","article-title":"Proteinase-activated receptors","volume":"53","author":"Macfarlane","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.107.038158_REF57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.neuro.26.043002.094919","article-title":"Epidemiology of neurodegeneration","volume":"26","author":"Mayeux","year":"2003","journal-title":"Annu Rev Neurosci"},{"key":"10.1124\/mol.107.038158_REF58","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ijc.21207","article-title":"Association of a single nucleotide polymorphism in the matrix metalloproteinase-1 promoter with glioblastoma","volume":"117","author":"McCready","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1124\/mol.107.038158_REF59","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1124\/mol.107.038158_REF60","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"McGeer","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1124\/mol.107.038158_REF61","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1471-4159.2005.03117.x","article-title":"Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice","volume":"93","author":"Nagai","year":"2005","journal-title":"J Neurochem"},{"key":"10.1124\/mol.107.038158_REF62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3171\/jns.1994.81.1.0069","article-title":"Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors","volume":"81","author":"Nakagawa","year":"1994","journal-title":"J Neurosurg"},{"key":"10.1124\/mol.107.038158_REF63","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1046\/j.1460-9568.1998.00183.x","article-title":"Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion","volume":"10","author":"Niclou","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.107.038158_REF64","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1523\/JNEUROSCI.5200-04.2005","article-title":"Activation of protease-activated receptor-1 triggers astrogliosis after brain injury","volume":"25","author":"Nicole","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/mol.107.038158_REF65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-8993(90)91526-M","article-title":"Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"521","author":"O\u2019Callaghan","year":"1990","journal-title":"Brain Res"},{"key":"10.1124\/mol.107.038158_REF66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu Rev Neurosci"},{"key":"10.1124\/mol.107.038158_REF67","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1124\/mol.107.038158_REF68","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.1100135","article-title":"Cleavage of proBDNF by tPA\/plasmin is essential for long-term hippocampal plasticity","volume":"306","author":"Pang","year":"2004","journal-title":"Science"},{"key":"10.1124\/mol.107.038158_REF69","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1098-1136(199711)21:3<327::AID-GLIA7>3.0.CO;2-1","article-title":"Glucose transporter Glut 5 expression in microglial cells","volume":"21","author":"Payne","year":"1997","journal-title":"Glia"},{"key":"10.1124\/mol.107.038158_REF70","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1074\/jbc.M307657200","article-title":"NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia","volume":"279","author":"Qin","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.038158_REF71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.toxlet.2003.12.006","article-title":"Acute exposure to aroclor 1016 or 1260 differentially affects dopamine transporter and vesicular monoamine transporter 2 levels","volume":"148","author":"Richardson","year":"2004","journal-title":"Toxicol Lett"},{"key":"10.1124\/mol.107.038158_REF72","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1071699","article-title":"Activation of endothelial cell protease activated receptor 1 by the protein C pathway","volume":"296","author":"Riewald","year":"2002","journal-title":"Science"},{"key":"10.1124\/mol.107.038158_REF73","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2004.02785.x","article-title":"Reduced MPTP toxicity in noradrenaline transporter knockout mice","volume":"91","author":"Rommelfanger","year":"2004","journal-title":"J Neurochem"},{"key":"10.1124\/mol.107.038158_REF74","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/exnr.2002.7960","article-title":"Role of TNF-alpha receptors in mice intoxicated with the parkinsonian toxin MPTP","volume":"177","author":"Rousselet","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1124\/mol.107.038158_REF75","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nm0303-258","article-title":"PAR1 signaling: more good than harm?","volume":"9","author":"Ruf","year":"2003","journal-title":"Nat Med"},{"key":"10.1124\/mol.107.038158_REF76","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-1-6","article-title":"Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson\u2019s disease","volume":"1","author":"S\u00e1nchez-Pernaute","year":"2004","journal-title":"J Neuroinflammation"},{"key":"10.1124\/mol.107.038158_REF77","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3565(24)37972-8","article-title":"CEP-1347\/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo","volume":"288","author":"Saporito","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.038158_REF78","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-0270(93)90147-J","article-title":"A one-step immunohistochemical method for detection of blood-brain barrier disturbances for immunoglobulins in lesioned rat brain with special reference to false-positive labelling in immunohistochemistry","volume":"46","author":"Schmidt-Kastner","year":"1993","journal-title":"J Neurosci Methods"},{"key":"10.1124\/mol.107.038158_REF79","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s007020100004","article-title":"Neurochemical findings in the MPTP model of Parkinson\u2019s disease","volume":"108","author":"Schmidt","year":"2001","journal-title":"J Neural Transm"},{"key":"10.1124\/mol.107.038158_REF80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V62.2.333.333","article-title":"The endotoxin-induced procoagulant of mouse exudate macrophages: a factor-X activator","volume":"62","author":"Shands","year":"1983","journal-title":"Blood"},{"key":"10.1124\/mol.107.038158_REF81","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1182\/blood.V65.1.169.169","article-title":"Macrophage factor X activator formation: metabolic requirements for synthesis of components","volume":"65","author":"Shands","year":"1985","journal-title":"Blood"},{"key":"10.1124\/mol.107.038158_REF82","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0169-328X(02)00354-6","article-title":"Plasminogen mRNA induction in the mouse brain after kainate excitation: codistribution with plasminogen activator inhibitor-2 (PAI-2) mRNA","volume":"104","author":"Sharon","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1124\/mol.107.038158_REF83","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1158\/1541-7786.395.2.7","article-title":"Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis","volume":"2","author":"Shi","year":"2004","journal-title":"Mol Cancer Res"},{"key":"10.1124\/mol.107.038158_REF84","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0014-5793(99)01657-9","article-title":"Expression of factor X in both the rat brain and cells of the central nervous system","volume":"463","author":"Shikamoto","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.107.038158_REF85","first-page":"60","article-title":"Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development","volume":"144","author":"Soifer","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1124\/mol.107.038158_REF86","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1124\/mol.64.5.1199","article-title":"Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes","volume":"64","author":"Sorensen","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.038158_REF87","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.0022-3042.2001.00745.x","article-title":"Participation of protease-activated receptor-1 in thrombin-induced microglial activation","volume":"80","author":"Suo","year":"2002","journal-title":"J Neurochem"},{"key":"10.1124\/mol.107.038158_REF88","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1568010043483953","article-title":"Thrombin: a potential proinflammatory mediator in neurotrauma and neurodegenerative disorders","volume":"3","author":"Suo","year":"2004","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1124\/mol.107.038158_REF89","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.0.CO;2-#","article-title":"Environmental, medical, and family history risk factors for Parkinson\u2019s disease: a New England-based case control study","volume":"88","author":"Taylor","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1124\/mol.107.038158_REF90","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1124\/mol.107.038158_REF91","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1084\/jem.159.4.1042","article-title":"Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII\/VIIa protease activity","volume":"159","author":"Tsao","year":"1984","journal-title":"J Exp Med"},{"key":"10.1124\/mol.107.038158_REF92","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00019052-200108000-00009","article-title":"The role of glial cells in Parkinson\u2019s disease","volume":"14","author":"Vila","year":"2001","journal-title":"Curr Opin Neurol"},{"key":"10.1124\/mol.107.038158_REF93","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/353674a0","article-title":"Domains specifying thrombin-receptor interaction","volume":"353","author":"Vu","year":"1991","journal-title":"Nature"},{"key":"10.1124\/mol.107.038158_REF94","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1515\/BC.2003.021","article-title":"Thrombin signaling in the brain: the role of protease-activated receptors","volume":"384","author":"Wang","year":"2003","journal-title":"Biol Chem"},{"key":"10.1124\/mol.107.038158_REF95","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/glia.10012","article-title":"Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling","volume":"37","author":"Wang","year":"2002","journal-title":"Glia"},{"key":"10.1124\/mol.107.038158_REF96","doi-asserted-by":"crossref","first-page":"C1351","DOI":"10.1152\/ajpcell.00001.2002","article-title":"Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways","volume":"283","author":"Wang","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/mol.107.038158_REF97","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1523\/JNEUROSCI.15-04-02906.1995","article-title":"Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA","volume":"15","author":"Weinstein","year":"1995","journal-title":"J Neurosci"},{"key":"10.1124\/mol.107.038158_REF98","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/mol.107.038158_REF99","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.107.038158_REF100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pharmthera.2004.10.007","article-title":"Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson\u2019s disease","volume":"105","author":"Xu","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.107.038158_REF101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02331429","article-title":"Immunohistochemical studies of human tissues with antibody to factor Xa","volume":"28","author":"Yamada","year":"1996","journal-title":"Histochem J"},{"key":"10.1124\/mol.107.038158_REF102","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.10709","article-title":"Minocycline enhances MPTP toxicity to dopaminergic neurons","volume":"74","author":"Yang","year":"2003","journal-title":"J Neurosci Res"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24045619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24045619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.107.038158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:54:58Z","timestamp":1739966098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24045619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0026895X24045619"],"URL":"https:\/\/doi.org\/10.1124\/mol.107.038158","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exacerbation of Dopaminergic Terminal Damage in a Mouse Model of Parkinson\u2019s Disease by the G-Protein-Coupled Receptor Protease-Activated Receptor 1","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.107.038158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}